Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 50 Carcinoma, Non-Small-Cell Lung 26 Squamous Cell Carcinoma of Head and Neck 25 Head and Neck Neoplasms 12 Neoplasm Metastasis 11 Neoplasms 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Pancreatic Neoplasms 9 Lung Neoplasms 9 Mouth Neoplasms 6 Carcinoma, Squamous Cell 6 Carcinoma 6 Laryngeal Neoplasms 5 Hypopharyngeal Neoplasms 5 Oropharyngeal Neoplasms 4 Thyroid Neoplasms 3 Solid Tumors 3 Ovarian Neoplasms 3 Gastrointestinal Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Pancreatic Ductal 3 Breast Neoplasms 3 Sarcoma 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Laryngeal Diseases 2 mCRC 1 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

Injections 8 pembrolizumab 4 Pemetrexed 4 Carboplatin 4 Oxaliplatin 3 Leucovorin 3 Fluorouracil 3 trifluridine tipiracil drug combination 2 sotorasib 2 fludarabine 2 Paclitaxel 2 Drug Therapy 2 Docetaxel 2 Bevacizumab 2 zimberelimab 1 trametinib 1 toripalimab 1 tislelizumab 1 sacituzumab govitecan 1 netrin-1 inhibitor NP137 1 cemiplimab 1 WW Domain-Containing Oxidoreductase 1 SYS6006 COVID-19 vaccine 1 Panitumumab 1 Irinotecan 1 Immune Checkpoint Inhibitors 1 Etoposide 1 Cyclophosphamide 1 Cisplatin 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumors × Cetuximab × 90 days × Clear all

NCT05067283 2026-05-26

KANDLELIT-001

Merck Sharp & Dohme LLC

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡